Back to top

CARM forms Gilligan's Island Buy Setup on April 27

Carisma Therapeutics, Inc. (CARM) Technical Analysis, Stock Scans & Trading Signals · Apr 28, 2026, 02:12 ET
CARM posted a 95.45% loss on Monday, April 27th, accompanied by 0.3× normal trading volume. Mixed technical signals appeared with Gilligan's Island Buy Setup suggesting upside potential, while New 52 Week Closing Low indicated possible weakness — creating a conflicted technical picture. Key support levels exist at 0.0, 0.0 & 0.0, with resistance at 0.0, 0.0 & 0.0. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of CARM: F

Just a sneak peek — check SwingTradeBot.com for the full story on CARM.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Carisma Therapeutics Inc. (CARM)